Mbx Biosciences reported raising $46.7 Million in an initial SEC Form D filing, from an offering of $115 Million
Round Type
Venture
CarmelBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaWho else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as MBX Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- Citius Pharmaceuticals, Inc. raised $3.6M (Seed) on November 21, 2022.
- Renibus Therapeutics raised $33M (Funding Round) on November 14, 2022.
Who to call at MBX Biosciences, Inc., and when
A new round usually means MBX Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MBX Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MBX Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MBX Biosciences, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MBX Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MBX Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.